Physician profile
Chen K Young
NPI 1871538876
$45,817.24
in general payments reported to CMS, 2019-2025
16 companies · $9,535 in 2025
The $9,535 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $888 · 2021: $5,978 · 2022: $1,726 · 2023: $4,696 · 2024: $10K · 2025: $9,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $3,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,500.00 |
| Food and Beverage | $3,109.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $40,148.52 | 2019-2025 | Precision 1, Dailies Total1, Air Optix Color |
| Carl Zeiss Meditec USA, INC. | $1,891.24 | 2021-2024 | Cirrus Hd-Oct, Atlas Corneal Topography System, Humphrey Matrix |
| Bausch & Lomb Americas INC. | $1,363.61 | 2022-2025 | Infuse, Alden Scleral Zenlens, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $666.88 | 2019-2021 | |
| Allergan, INC. | $376.51 | 2020-2022 | |
| Carl Zeiss Meditec, INC. | $303.94 | 2019-2020 | |
| Abb Con-Cise Optical Group LLC | $218.90 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $206.38 | 2021-2024 | |
| Topcon Healthcare, INC. | $190.23 | 2021-2024 | |
| Glaukos Corporation | $182.10 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $126.75 | 2025 | Xdemvy |
| Coopervision INC. | $75.79 | 2021 | |
| Abbvie INC. | $20.77 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.77 | 2020 | |
| Shire North American Group INC | $16.53 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chen Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.